3. Summary
In 2009, the global Osteoporosis drug market was worth USD 6.8 billion,
with Bisphosphonate class of drugs leading the market. In the overall
Bisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate
(Aclasta/Zometa; Novartis) accounted largest share in class, respectively,
and showed an average sales growth rate of about of 20% in the past 2
years.
Amgen’s Denosumab is the recent entrant to the Osteoporosis treatment
market, following its approval from the U.S. and European Union (also
approved for bone loss associated with prostate cancer). Denosumab is
expected to compete directly with the Bisphosphonate drug class. However,
initial uptake of Denosumab is likely to be as second-line therapy, mostly in
patients who are intolerant to Bisphosphonate. In addition to the treatment
of Osteoporosis, there is substantial potential for Denosumab for treating
bone loss in patients with cancer. Denosumab market is expected to reach
USD 3.8 billion in 2015.
4. Scope
The objective of the study on “Global and China Osteoporosis Drug Industry
Analysis and Forecast (2009 – 2015)” is to gain detailed market insights for key
Osteoporosis drugs market segments. The market is analyzed on the basis of
growth trends, ongoing developments, market penetration and revenue share.
The report also covers the strategies followed by “Osteoporosis Drugs Market”
players.
Segmentation & Analysis
The report segments and analyzes the “Osteoporosis Drugs Market” on the basis
of following sub-categories:
• Geographic Markets
o Global
o China
5. Table of Contents :
CHAPTER 1 EXECUTIVE SUMMARY
CHAPTER 2 CHINA OSTEOPOROSIS MARKET ANALYSIS, 2009 – 2015
2.1 MARKET OVERVIEW
2.2 50+ CHINESE POPULATION GROWTH TREND 2007 - 2050
2.3 CHINA POPULATION AGE STRUCTURE, 2010
2.4 CHINESE POPULATION WITH OSTEOPOROSIS, 2008 - 2050 (MILLION)
2.5 DRIVING FACTOR ANALYSIS OF CHINA OSTEOPOROSIS MARKET
2.5.1 BARGAINING POWER OF CUSTOMERS: MEDIUM/HIGH
2.5.2 BARGAINING POWER OF SUPPLIERS: LOW
2.5.3 THREAT OF SUBSTITUTE PRODUCTS: MEDIUM
2.5.4 THREAT OF ENTRY OF NEW COMPETITORS: LOW
2.5.5 INTENSITY OF COMPETITIVE RIVALRY: HIGH
2.6 APPROVED OSTEOPOROSIS TREATMENT LANDSCAPE
2.7 COMPETITIVE STRATEGIES……………..
6. More Reports:
Osteoporosis Drug Market- Global And China Market Analysis, Size,
Trends And Forecast (2010-2015)
Excipients Market - Global Industry Analysis, Market Size, Share,
Trends, Analysis, Growth And Forecast, 2012 - 2018
Glass Tableware Market - Global And Egypt Industry Analysis,
Market Size, Trends And Forecast, 2011 - 2017
Biofuel Enzymes Market - Global Industry Size, Market Share,
Trends, Analysis And Forecast, 2012 - 2018
Ostomy Drainage Bags Market - Global Industry Size, Market Share,
Trends, Analysis, And Forecasts, 2012 - 2018
7. Infertility Drugs And Devices Market - Global Industry Analysis,
Size, Share And Forecast, 2010 - 2017
Brazilian Animal Feed Additives Market - Industry Analysis,
Market Size, Share, Growth And Forecast, 2011 - 2018
Butanediol (1,4 BDO & 2,3 BDO), 1,3 Butadiene And Methyl Ethyl
Ketone (MEK) Market: Applications (THF, PU, PBT, SBR, ABS, NBR
Etc.), Bio-Based Alternatives, Downstream Potential, Market Size
And Forecast, 2010 - 2018
Green Packaging Market (Recycled, Reusable & Degradable) -
Global Scenario, Trends, Industry Analysis, Size, Share And
Forecast, 2011 - 2018
Commercial Refrigeration Equipment Market : Global Industry
Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
In Vitro Toxicity Testing Market - Global Industry Size, Share,
Trends, Analysis And Forecast, 2012 - 2018
8. For More details about above & other
Reports plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore